Table:
begin	end	state
1	17	cytoplasmic
18	38	transmembrane
39	43	non-cytoplasmic
44	63	transmembrane
64	88	cytoplasmic
89	119	transmembrane
120	124	non-cytoplasmic
125	144	transmembrane
145	154	cytoplasmic
155	177	transmembrane
178	199	non-cytoplasmic
200	223	transmembrane
224	242	cytoplasmic
243	263	transmembrane
264	280	non-cytoplasmic
281	302	transmembrane
303	332	cytoplasmic
333	354	transmembrane
355	359	non-cytoplasmic
360	382	transmembrane
383	402	cytoplasmic
403	424	transmembrane
425	429	non-cytoplasmic
430	449	transmembrane
450	469	cytoplasmic

Input:
>Pf1N1B4_1580
MQQPAKGLKRGLSARHIRFMALGSAIGTGLFYGSASAIQMAGPAVLLAYLIGGAAVFMVM
RALGEMAVHNPVAGSFGQYASTYLGPMAGFILGWTYAFEMVIVGMADVTAFGIYMGFWFP
EVDRWIWVLGIVSVVGGLNLCNVKVFGEMEFWLSLLKVAAIVAMILGGFGIMLFGISTAP
GAQATDISNLWSHGGFMPNGVGGLIASFAVVMFAFGGIEIIGVTAGEAKDPQRVLPRAIN
AVPLRILLFYVLTMLVLMSIFPWQQIGSQGSPFVQIFDNLGISSAATILNIVVISAAVSA
INSDIFGAGRMMYGLAQQGHAPKGFARLSRNGVPWLTVVVMSSALLLGVLLNYLIPENVF
LLIASVATFATVWVWLMILFTQVAMRRSMSAEQVAQLKFPVPFWPYAPMAAIAFMLFIFG
VLGYFPDTQAALIVGVVWIVLLVLAYLTWVKPAAGQAALVARDPDFSHR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server